When science and the law converge, Carl is there to help Life Science companies prepare patents and monetize their intellectual property.

Carl develops intellectual property protection processes, from conception through patent issuance and commercialization of products, on behalf of chemical, biotech, and pharmaceutical companies. In the role of strategic counselor for life sciences firms with extensive patent portfolios, he has represented companies developing and marketing small molecule drugs, as well as those developing therapeutic and diagnostic biotechnology. His practice includes counseling companies developing cancer immunotherapies, as well as diagnostic tests and companion diagnostics/theranostics. Carl also has prepared applications and prosecuted patents relating to novel nucleic acids, proteins, antibodies, vaccines, transgenic animals, and gene therapy.

He has helped universities, including Duke, U.C. Berkeley, Emory and Harvard, manage and explore ways to exploit their patent portfolios.

Experience

Any result the lawyer or law firm may have achieved on behalf of clients in other matters does not necessarily indicate similar results can be obtained for other clients.

  • Patent counseling and portfolio development for a small molecule drug company achieving record-breaking private financing, three major partnerships with big pharm (largest having a total deal value of ~ $1B, with $200M upfront), and a very successful initial public offering. His activities included preparation for and conduct of due diligence for this client as target, vetting of all IP aspects of associated Joint Development Agreements, as well as opinion work and development of internal IP management procedures.
  • Patent counseling and portfolio development for a billion dollar spin-out of a big pharma biological products division, through private equity purchase, IPO, and acquisition by a major foreign company in the space. Carl prepared opinions and analyses regarding several projects in extremely valuable and competitive biologic therapeutics area. He also managed European counsel through several opposition proceedings challenging a major patent portfolio of this client, with successful outcomes resulting in a licensing arrangement with the opposing party.
  • Patent prosecution, counseling, and due diligence for a large diagnostics company through acquisition of three university spin-out companies.
Share

Bar admissions

1997, Virginia

1999, North Carolina

Admitted to practice before:

  • US Patent and Trademark Office
  • All Virginia and North Carolina State Courts
  • Fourth Circuit Court of Appeals

Education

  • J.D., 1997, Boston University School of Law
    • cum laude
  • M.S., Biochemistry, 1994, Duke University
  • M.S., Biology, 1990, University of Alabama at Birmingham
  • B.S., 1986, Wake Forest University
    • cum laude